Cuprotosis Programmed-Cell-Death-Related lncRNA Signature Predicts Prognosis and Immune Landscape in PAAD Patients
Hao Chi(Southwest Medical University), Gang Tian(Southwest Medical University), Xixi Xie(Southwest Medical University), Fengyi Yang(Affiliated Hospital of Southwest Medical University), Ke Xu(First People's Hospital of Chongqing), Rui Wang(Sun Yat-sen University), Xiaoli Yang(Army Medical University), Gaoge Peng(Southwest Medical University), Jinhao Zhang(Southwest Medical University), Tao Gu(Southwest Medical University)
Cited by 66
Related Papers
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension
|New England Journal of Medicine|2021|742
Analysis of Tumor Metabolism Reveals Mitochondrial Glucose Oxidation in Genetically Diverse Human Glioblastomas in the Mouse Brain In Vivo
|Cell Metabolism|2012|532
Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in Youth
|JAMA|2015|416
Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial
|Journal of Thoracic Oncology|2021|311